Literature DB >> 10815738

Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.

H Lee1, S N Cho, H E Bang, J H Lee, G H Bai, S J Kim, J D Kim.   

Abstract

SETTING: The single base change at the 94th codon of inhA has been referred to as the event that confers resistance on the drugs isoniazid (INH) and ethionamide (ETH) in Mycobacterium smegmatis and M. bovis. From this observation, it has been anticipated that some of the INH-resistant clinical isolates of M. tuberculosis would carry missense mutations in the same region of the gene. However, few polymorphisms have been identified in this region among INH-resistant isolates.
OBJECTIVE: To understand the molecular basis for M. tuberculosis resistance to INH and ETH.
DESIGN: The sequence polymorphism at the 94th codon of inhA among M. tuberculosis isolates from Korea was analyzed by polymerase chain reaction (PCR) cloning and sequence analysis.
RESULTS: No nucleotide change at the 94th codon of inhA was detected in any of the 24 INH-resistant isolates analyzed in this study. On the other hand, a point mutation was found exclusively at the regulatory region flanking a putative ribosome-binding site of the inhA locus in 14 isolates. Interestingly, all the mutations were of the same kind, which substitutes C to T. Among 14 isolates, 12 were resistant to INH as well as to ETH, while two were resistant to INH only. DISCUSSION: It seems that mutations previously found at the 94th codon of inhA have no particular relationship with the mechanism involved in the resistance of M. tuberculosis to INH and/or ETH. On the other hand, the resistance mechanism of M. tuberculosis to INH/ETH may involve an altered level of InhA, an expression which may have been influenced by the sequence change in the regulatory region of the inhA locus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815738

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  13 in total

1.  Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis.

Authors:  V R Bollela; E I Namburete; C S Feliciano; D Macheque; L H Harrison; J A Caminero
Journal:  Int J Tuberc Lung Dis       Date:  2016-08       Impact factor: 2.373

2.  Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis.

Authors:  F Brossier; N Veziris; C Truffot-Pernot; V Jarlier; W Sougakoff
Journal:  Antimicrob Agents Chemother       Date:  2010-10-25       Impact factor: 5.191

Review 3.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

4.  Biological and molecular characteristics of Mycobacterium tuberculosis clinical isolates with low-level resistance to isoniazid in Japan.

Authors:  Chiyoji Abe; Ikuo Kobayashi; Satoshi Mitarai; Masako Wada; Yoshiko Kawabe; Tetsuya Takashima; Katsuhiro Suzuki; Li-Hwei Sng; Suxing Wang; Hla Hla Htay; Hideo Ogata
Journal:  J Clin Microbiol       Date:  2008-05-28       Impact factor: 5.948

5.  Genotypic and phenotypic characteristics of tunisian isoniazid-resistant Mycobacterium tuberculosis strains.

Authors:  Alya Soudani; Sondess Hadjfredj; Meriem Zribi; Feriel Messaadi; Taieb Messaoud; Afef Masmoudi; Mohamed Zribi; Chedlia Fendri
Journal:  J Microbiol       Date:  2011-06-30       Impact factor: 3.422

6.  Direct observation therapy with appropriate treatment regimens was associated with a decline in second-line drug-resistant tuberculosis in Taiwan.

Authors:  J-Y Chien; C-C Tsou; S-T Chien; C-J Yu; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-12-12       Impact factor: 3.267

7.  ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates.

Authors:  Glenn P Morlock; Beverly Metchock; David Sikes; Jack T Crawford; Robert C Cooksey
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

8.  Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.

Authors:  Johana Rueda; Teresa Realpe; Gloria Isabel Mejia; Elsa Zapata; Juan Carlos Rozo; Beatriz Eugenia Ferro; Jaime Robledo
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

Review 9.  Current issues on molecular and immunological diagnosis of tuberculosis.

Authors:  Sang-Nae Cho
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

10.  Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients.

Authors:  Matthias Merker; Thomas A Kohl; Andreas Roetzer; Leona Truebe; Elvira Richter; Sabine Rüsch-Gerdes; Lanfranco Fattorini; Marco R Oggioni; Helen Cox; Francis Varaine; Stefan Niemann
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.